1217 related articles for article (PubMed ID: 15592455)
1. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
Rush J; Moritz A; Lee KA; Guo A; Goss VL; Spek EJ; Zhang H; Zha XM; Polakiewicz RD; Comb MJ
Nat Biotechnol; 2005 Jan; 23(1):94-101. PubMed ID: 15592455
[TBL] [Abstract][Full Text] [Related]
2. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).
Amanchy R; Kalume DE; Iwahori A; Zhong J; Pandey A
J Proteome Res; 2005; 4(5):1661-71. PubMed ID: 16212419
[TBL] [Abstract][Full Text] [Related]
3. Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: implications for adjuvant use of kinase-inhibitory drugs.
Lim YP; Wong CY; Ooi LL; Druker BJ; Epstein RJ
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3980-7. PubMed ID: 15217928
[TBL] [Abstract][Full Text] [Related]
4. Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.
Yan GR; Xiao CL; He GW; Yin XF; Chen NP; Cao Y; He QY
Proteomics; 2010 Mar; 10(5):976-86. PubMed ID: 20049867
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of enrichment techniques for mass spectrometry: identification of tyrosine phosphoproteins in cancer cells.
Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
J Mol Diagn; 2007 Apr; 9(2):169-77. PubMed ID: 17384208
[TBL] [Abstract][Full Text] [Related]
6. An enriched look at tyrosine phosphorylation.
Conrads TP; Veenstra TD
Nat Biotechnol; 2005 Jan; 23(1):36-7. PubMed ID: 15637616
[No Abstract] [Full Text] [Related]
7. Proteomic analysis reveals novel molecules involved in insulin signaling pathway.
Wang Y; Li R; Du D; Zhang C; Yuan H; Zeng R; Chen Z
J Proteome Res; 2006 Apr; 5(4):846-55. PubMed ID: 16602692
[TBL] [Abstract][Full Text] [Related]
8. A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways.
Mukherji M; Brill LM; Ficarro SB; Hampton GM; Schultz PG
Biochemistry; 2006 Dec; 45(51):15529-40. PubMed ID: 17176074
[TBL] [Abstract][Full Text] [Related]
9. Immunoaffinity enrichments followed by mass spectrometric detection for studying global protein tyrosine phosphorylation.
Bergström Lind S; Molin M; Savitski MM; Emilsson L; Aström J; Hedberg L; Adams C; Nielsen ML; Engström A; Elfineh L; Andersson E; Zubarev RA; Pettersson U
J Proteome Res; 2008 Jul; 7(7):2897-910. PubMed ID: 18543961
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks.
Zhang Y; Wolf-Yadlin A; White FM
Methods Mol Biol; 2007; 359():203-12. PubMed ID: 17484120
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.
Chang YC; Lin SY; Liang SY; Pan KT; Chou CC; Chen CH; Liao CL; Khoo KH; Meng TC
J Proteome Res; 2008 Mar; 7(3):1055-66. PubMed ID: 18281928
[TBL] [Abstract][Full Text] [Related]
12. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
13. Targeted analysis of tyrosine phosphorylation by immuno-affinity enrichment of tyrosine phosphorylated peptides prior to mass spectrometric analysis.
Zoumaro-Djayoon AD; Heck AJ; Muñoz J
Methods; 2012 Feb; 56(2):268-74. PubMed ID: 21945579
[TBL] [Abstract][Full Text] [Related]
14. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation.
Yang F; Stenoien DL; Strittmatter EF; Wang J; Ding L; Lipton MS; Monroe ME; Nicora CD; Gristenko MA; Tang K; Fang R; Adkins JN; Camp DG; Chen DJ; Smith RD
J Proteome Res; 2006 May; 5(5):1252-60. PubMed ID: 16674116
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic approaches for studying phosphotyrosine signaling.
Ding SJ; Qian WJ; Smith RD
Expert Rev Proteomics; 2007 Feb; 4(1):13-23. PubMed ID: 17288512
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of potential Stat3-regulated genes in human breast cancer.
Hsieh FC; Cheng G; Lin J
Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
[TBL] [Abstract][Full Text] [Related]
17. Profiling protein tyrosine phosphorylation: a quantitative 45-plex peptide-based immunoassay.
Nadler TK; Rauh-Adelmann C; Murphy C; Hall AB; Graham JR; Yen L; Gordon NF; Radding JA
J Biomol Screen; 2008 Aug; 13(7):626-37. PubMed ID: 18626117
[TBL] [Abstract][Full Text] [Related]
18. Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment.
Nagano K; Shinkawa T; Mutoh H; Kondoh O; Morimoto S; Inomata N; Ashihara M; Ishii N; Aoki Y; Haramura M
Proteomics; 2009 May; 9(10):2861-74. PubMed ID: 19415658
[TBL] [Abstract][Full Text] [Related]
19. Detection of tyrosine phosphorylated peptides via skimmer collision-induced dissociation/ion trap mass spectrometry.
Zolodz MD; Wood KV
J Mass Spectrom; 2003 Mar; 38(3):257-64. PubMed ID: 12644986
[TBL] [Abstract][Full Text] [Related]
20. Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.
Tong J; Taylor P; Jovceva E; St-Germain JR; Jin LL; Nikolic A; Gu X; Li ZH; Trudel S; Moran MF
J Proteome Res; 2008 Mar; 7(3):1067-77. PubMed ID: 18271526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
